Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 4 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
GeMu Farma from Brakel, company number BE0754670094, closed financial year 2025 with a result of € 78,166 after tax. For that financial year GeMu Farma recorded a gross margin of € 118,526 and equity of € 154,731. Compared with financial year 2024, the result moved from € 6,354 to € 78,166. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on March 25, 2026.
€ 154,731
▲ 102% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 78,166
▲ € 71,811 vs 2024
Profit after tax over the fiscal year.
€ 9,496
▲ 15% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 104,731.
People and assets in 2025
0
Average over the fiscal year, from the social balance sheet.
€ 141
▼ 93% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 502,054
▼ 12% vs 2024
€ 78,000 is repaid this year. At this pace the long-term loan is gone in ≈ 6 years.
€ 533
▼ 44% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 3,392
▲ 56% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 27,747 | € 24,150 | € 24,159 | € 118,526 | ▲ € 94,366 |
| Profit after taxes | € 11,900 | € 8,369 | € 6,354 | € 78,166 | ▲ € 71,811 |
| Equity | € 61,842 | € 70,211 | € 76,565 | € 154,731 | ▲ 102% |
| Total debts | € 765,939 | € 757,061 | € 748,967 | € 669,742 | ▼ 11% |
| Cash | € 7,841 | € 9,091 | € 8,271 | € 9,496 | ▲ 15% |
| Retained profit | € 11,842 | € 20,211 | € 26,565 | € 104,731 | ▲ 294% |
| Bank debt | € 713,000 | € 641,000 | € 569,000 | € 502,054 | ▼ 12% |
| Balance sheet total | € 827,781 | € 827,272 | € 825,532 | € 824,473 |
Key figures of GeMu Farma, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.
What happened to GeMu Farma?
What happened at GeMu Farma in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 78,166 (▲ € 71,811 vs 2024). Source: NBB ↗
- New establishment in Brakel. KBO
- Start of the company according to the CBE. KBO
In short
From € 11,900 profit in 2022 to € 78,166 profit in 2025.
Paid € 36,995 in corporate taxes since 2022.
Best year ever: 2025, with € 78,166 profit.
Management
Behind GeMu Farma is Veerle De Geyter. It owns 100% of Apotheek De Geyter itself.
Directors
According to the 2025 annual accounts
Veerle De Geyter
Director
Establishments
Establishment units
Physical locations of this company
Geraardsbergsestraat 127
9660 Brakel
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0754.670.094
- VAT number
- BE 0754.670.094
- Registered office
- Geraardsbergsestraat 127, 9660 Brakel
- Names & denominations
- GeMu Farma
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 21 September 2020
- Peppol
- Active · Active since 8 Jul 2025
- Activities · NACE
Activiteiten van holdings
Holdings
Administratieve en ondersteunende activiteiten ten behoeve van kantoren
Overige zakelijke dienstverlening, neg
Diverse administratieve activiteiten ten behoeve van kantoren